Results 31 to 40 of about 8,888 (168)

Maternal and neonatal outcomes in Gaza amid armed hostilities in 2025

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This study documents facility‐based maternal, obstetric, and neonatal outcomes and associated conflict‐related exposures and living conditions among pregnancy‐related encounters at Al‐Helou Maternity Hospital in Gaza from late April to early September 2025, with a small number of additional encounters recorded at Al‐Shifa Medical ...
Shaymaa Abuhaiba, Younis Elijla, Aya El‐Dadah, Othman Nassar, Meran Abu‐Sultan, Maysaa Almasry, Hebatallah Alkhatib, Mahmoud Alsady, Amir Mahdi Ghafarian, Muath Alsarafandi, Lina Abumughessib, Arham Ali, Yassar Arain, Abeerah Muhammad, Belal Aldabbour, Shayan Ali, Bilal Irfan   +16 more
wiley   +1 more source

Estudio comparativo en el manejo médico del aborto terapéutico entre el uso de mifepristone más misoprostol y el uso de misoprostol solo

Revista Peruana de Investigación Materno Perinatal, 2019
Objetivos: Evaluar las diferencias en el manejo médico del aborto terapéutico usando Mifepristone más Misoprostol comparado con el uso de Misoprostol solo.
Enrique Guevara-Ríos, Antonio Luna-Figueroa, Miguel Gutiérrez-Ramos, Félix Dasio Ayala-Peralta, Cesar Carranza-Asmat, Pedro Arango-Ochante, Marcos Espinola-Sánchez, Percy Minaya-León, Pedro Mascaro-Sánchez, Juan Díaz-Villar, Felipe Loo-Choy, Luis Kobayashi-Tsutsumi, Dennys Celedonio-Salvador, Luis Almeyda-Castro, Jhony Juarez-Montalvan, Leonardo Lachira-León, Luis Makiya-Onaga, Fredy Jesús Cabrera-Olórtegui, Melisa Mejico Caja, Augusto Racchumí-Vela   +19 more
doaj   +1 more source

Maternal infection in the context of actively managed prelabor rupture of membranes at term: An observational study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To assess maternal infection following prelabor rupture of membranes (PROM) at term in a setting where active management is recommended, and to identify associated risk factors. Methods A retrospective cohort study was conducted including pregnant women admitted to a Portuguese tertiary care center where immediate induction of labor ...
Inês Martins, Inês Gomes Brou, Miguel Macedo, Luísa Pinto   +3 more
wiley   +1 more source

Rectal vs. sublingual misoprostol in cesarean section: three‑arm, randomized clinical trial

Caspian Journal of Internal Medicine, 2022
Background: Misoprostol is a myometrial stimulant with uterotonic properties and can be administered rectally, vaginally, or sublingually. Numerous studies have investigated the effect of misoprostol on the prevention and treatment of PPH (postpartum ...
Fatemeh Zahra Bagheri, Mahboobeh Azadehrah, Bizhan Shabankhani, Hooshang Akbari, Ebrahim Nasiri Ferami   +4 more
doaj  

An external validation study of a practical scoring system for identifying patients at risk of pelvic floor dysfunction following childbirth

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To prospectively evaluate the perineal card, a risk‐based scoring system, for identifying women at increased risk of postpartum urinary incontinence (UI). Methods This prospective observational study included women without previous vaginal delivery who underwent vaginal birth at a tertiary referral center between June 2023 and ...
Martina Arcieri, Michela Segatti, Filippo Bordin, Doriana Armenise, Maria De Martino, Miriam Isola, Chiara Mattiussi, Elisa Barbui, Sara Filippin, Veronica Tius, Cristina Delneri, Valeria Dialti, Stefano Restaino, Lorenza Driul, Giuseppe Vizzielli   +14 more
wiley   +1 more source

Acceptability of misoprostol-only medication abortion dispensed by mail-order or retail pharmacy: a qualitative study based on in-depth interviews in the United States

Sexual and Reproductive Health Matters
The WHO recommends two medication abortion regimens, either misoprostol used with mifepristone or misoprostol-only. Both regimens are recognised as safe and effective, but in the United States (US) most abortions are completed using mifepristone and ...
Dana M. Johnson, Sruthi Ramaswamy, Rebecca Gomperts   +2 more
doaj   +1 more source

Comparison of the Efficacy of Vaginal Misoprostol with and without Laminaria in Second Trimester Induction Abortion [PDF]

Journal of Kerman University of Medical Sciences, 2012
Background & Aims: Therapeutic abortion in the second trimester pregnancy is the choice treatment in cases with severe anomalies or intrauterine fetal death. It can be done by a number of medical (e.g. misoprostol) or mechanical methods (e.g. laminaria).
Z Salari, L SHarifi, B.SH Aali
doaj  

Complaints Involving Sonographers: What Three Decades of Cases From A Public New Zealand Database Can Teach Us

Journal of Medical Radiation Sciences, EarlyView.
Health consumer complaints to the New Zealand Health and Disability Commissioner involving sonographers are rare, totalling 15 in the last 31 years and averaging 1.5 cases per year over the last decade. A large proportion of complaints involve an undetected finding, obstetric examination and private setting.
Martin Necas, Claire Calver, Alex Hill, Danielle Mourits, Sarah Park, Carla Smith   +5 more
wiley   +1 more source

Is the Time of administration of misoprostol of value? The uterotonic effect of misoprostol given pre- and post-operative after elective cesarean section

Middle East Fertility Society Journal, 2014
Objective: The aim of the current study was to compare blood loss in pre- and post-operatively rectally administered 600 μg of misoprostol in elective cesarean delivery, in order to determine the optimal time for drug administration (CS). Study design: A
Ahmed H. Abd-Ellah, Abdel Aziz E. Tamam, Mostafa Mohammed Khodry   +2 more
doaj   +1 more source

Priming of labor with tafoxiparin in nulliparous term pregnant women with unripe cervix—Proof‐of‐concept and dose‐finding results from a randomized controlled trial

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
This study shows that tafoxiparin 300 mg can increase the rate of cervical ripening and the likelihood of spontaneous onset of labor, while also reducing the duration of labor in women achieving spontaneous onset of labor. The favorable safety profile of tafoxiparin suggests suitability for routine clinical use, including home administration.
Gunvor Ekman‐Ordeberg, Maria Jonsson, Marie Blomberg, Malin Melin, Ylva Stjernholm‐Vladic, Sebastian B. Gidlöf, Dag Wide‐Swensson, Kati Tihtonen, Inge C. Olsen, Lena Degling‐Wikingsson, Per Blom, Leena Rahkonen   +11 more
wiley   +1 more source